May 18, 2026

Rhythm Pharmaceuticals, Inc. (RYTM): Exploring a 52.67% Potential Upside in the Biotech Sector

Investors eyeing the healthcare sector, particularly in biotechnology, may find Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) an intriguing prospect. With a market capitalization of $6.2 billion, this commercial-stage biopharmaceutical company is..

Integer Holdings Corporation (ITGR) Stock Analysis: Healthcare Innovator with 10% Upside Potential

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, specializes in medical device contract development and manufacturing. With a market capitalization of $2.99 billion, this Plano, Texas-based..

Madrigal Pharmaceuticals (MDGL) Investor Outlook: Significant Potential Upside with a 28.77% Gain on the Horizon

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is gaining the attention of investors, standing out in the biotechnology sector with its focus on metabolic dysfunction-associated steatohepatitis (MASH) treatment. As a biopharmaceutical company..

Qiagen N.V. (QGEN) Investor Outlook: A 32.87% Upside Potential in the Diagnostics & Research Sector

Qiagen N.V. (QGEN), a prominent player in the diagnostics and research sector, is drawing significant attention from investors due to its potential 32.87% upside. Headquartered in Venlo, Netherlands, and boasting..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a 24.58% Potential Upside in the Biotech Sector

Sarepta Therapeutics, Inc. (SRPT) stands at the forefront of the biotechnology industry with a keen focus on developing RNA-targeted therapeutics and genetic therapies for rare diseases. Based in Cambridge, Massachusetts,..

RadNet, Inc. (RDNT)

⚠️ No article content returned.

..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Uncovering a 25.7% Potential Upside for Investors

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands out in the biotechnology sector with a robust market capitalization of $110.9 billion. This healthcare giant, headquartered in Boston, Massachusetts, has carved a niche..

Tempus AI, Inc. (TEM) Investor Outlook: Navigating the 52.97% Potential Upside in Health Information Services

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare technology sector with its comprehensive suite of diagnostic and data-driven solutions aimed at revolutionizing precision medicine. As a notable..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A Look at Growth Potential and Analyst Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector specializing in medical instruments and supplies, is drawing attention from investors with its robust growth potential and..

ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech with 102.54% Potential Upside

As investors scour the healthcare sector for promising opportunities, ADMA Biologics Inc (NASDAQ: ADMA) has emerged as a noteworthy contender in the biotechnology space. With a market capitalization of $1.92..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings Signal Promising Growth Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) stands out in the biotech sector, not just for its extensive portfolio of innovative therapies but also for its strong market performance and promising growth..

Alkermes plc (ALKS) Stock Analysis: Uncovering a 21% Upside Potential in Biopharmaceutical Innovation

Alkermes plc (NASDAQ: ALKS) is catching the attention of investors, with a compelling 21.23% potential upside as per the latest analyst ratings. This Dublin-based biopharmaceutical company is not only making..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Growth with a 52.60% Revenue Surge

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare plans industry, is gaining attention with its impressive revenue growth of 52.60%. As a healthcare technology company, Oscar Health..

Waystar Holding Corp. (WAY) Stock Analysis: Assessing the 93.75% Upside Potential

Waystar Holding Corp. (WAY), a key player in the Health Information Services industry, is capturing attention with an impressive potential upside of 93.75%, according to analyst ratings. As a cloud-based..

Stevanato Group S.p.A. (STVN) Stock Analysis: A 38% Potential Upside Draws Investor Attention

Stevanato Group S.p.A. (NYSE: STVN) is capturing the attention of investors with its robust presence in the healthcare sector, particularly within the medical instruments and supplies industry. With a significant..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Unlocking a 39.52% Potential Upside with Robust Buy Ratings

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $162.9 billion, the..

Prestige Consumer Healthcare (PBH): Investor Outlook Reveals 48.88% Potential Upside

Investors with an eye on the healthcare sector may find Prestige Consumer Healthcare Inc. (NYSE: PBH) a compelling opportunity, as the stock currently suggests a notable potential upside of 48.88%..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 10.76% Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector specializing in medical instruments and supplies, presents a compelling case for investors with its potential upside of 10.76%. Headquartered in..

Halozyme Therapeutics (HALO) Stock Analysis: A 27.3% Upside Potential Amid Strong Revenue Growth

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, is capturing investor attention with its robust growth prospects and potential upside. With a market capitalization of $7.96..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 15.23% Potential Upside Amid Robust Dividend Yield

Pfizer, Inc. (NYSE: PFE), a titan in the healthcare sector, is attracting considerable attention from investors with a compelling 15.23% potential upside based on its current trading metrics. With a..

Search

Funds

May 18, 2026

Search

Funds

May 18, 2026

FTSE 100

Funds